|Bid||0.0000 x 900|
|Ask||0.0000 x 800|
|Day's Range||3.6901 - 3.8500|
|52 Week Range||1.8600 - 5.4900|
|Beta (5Y Monthly)||0.71|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov. 25, 2013|
|1y Target Est||N/A|
New York, New York--(Newsfile Corp. - February 15, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Cellcom Israel Ltd. ("Cellcom" or the "Company") (NYSE: CEL). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 7980.The investigation concerns whether Cellcom and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining ...
NEW YORK, NY / ACCESSWIRE / February 11, 2021 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cellcom Israel Ltd. ("Cellcom" or "the Company") (NYSE:CEL).
Atlanta, Georgia--(Newsfile Corp. - February 8, 2021) - Holzer & Holzer, LLC is investigating whether Cellcom Israel Ltd. ("Cellcom Israel" or the "Company") (NYSE: CEL) complied with federal securities laws. On January 31, 2021, Cellcom Israel announced that Marathon 018 Xfone Ltd., the Company's cellular sharing network partner, had sent Cellcom Israel an annulment notice of the two companies' sharing agreement, "alleging that [Cellcom Israel] has materially breached the sharing agreement by acquiring ...